Detailed statistical analysis plan for the short-term versus long-term mentalisation-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder randomised clinical trial (MBT-RCT)

Sophie Juul, Sebastian Simonsen, Stig Poulsen, Susanne Lunn, Per Sørensen, Anthony Bateman, Janus Christian Jakobsen, Sophie Juul, Sebastian Simonsen, Stig Poulsen, Susanne Lunn, Per Sørensen, Anthony Bateman, Janus Christian Jakobsen

Abstract

Background: Psychotherapy for borderline personality disorder is often extensive and resource-intensive. Mentalisation-based therapy is a psychodynamically oriented treatment option for borderline personality disorder, which includes a case formulation, psychoeducation, and group and individual therapy. The evidence on short-term compared with long-term mentalisation-based therapy is currently unknown.

Methods/design: The Short-Term MBT Project (MBT-RCT) is a single-centre, parallel-group, investigator-initiated, randomised clinical superiority trial in which short-term (20 weeks) will be compared with long-term (14 months) mentalisation-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder. Outcome assessors, data managers, the data safety and monitoring committee, statisticians, and decision-makers will be blinded to treatment allocation. Participants will be assessed before randomisation and at 8, 16, and 24 months after randomisation. The primary outcome will be the severity of borderline symptomatology assessed with the Zanarini Rating Scale for Borderline Personality Disorder. Secondary outcomes will be functional impairment (Work and Social Adjustment Scale), quality of life (Short-Form Health Survey 36-mental component), global functioning (Global Assessment of Functioning), and proportion of participants with severe self-harm. In this paper, we present a detailed statistical analysis plan including a comprehensive explanation of the planned statistical analyses, methods to handle missing data, and assessments of the underlying statistical assumptions. Final statistical analyses will be conducted independently by two statisticians following the present plan.

Discussion: We have developed this statistical analysis plan before unblinding of the trial results in line with the Declaration of Helsinki and the International Conference on Harmonization of Good Clinical Practice Guidelines, which should increase the validity of the MBT-RCT trial by mitigation of analysis bias.

Trial registration: ClinicalTrials.gov NCT03677037 . Registered on 19 September 2018.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2021. The Author(s).

References

    1. Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford, England: Oxford University Press; 2016.
    1. Storebø OJ, Stoffers-Winterling JM, Völlm BA, Kongerslev MT, Mattivi JT, Jørgensen MS, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020;5:CD012955. 10.1002/14651858.CD012955.pub2.
    1. Juul S, Lunn S, Poulsen S, Sørensen P, Salimi M, Jakobsen JC, Bateman A, Simonsen S. Short-term versus long-term mentalization-based therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trial. Trials. 2019;20(1):196. doi: 10.1186/s13063-019-3306-7.
    1. World Medical Association World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi: 10.1001/jama.2013.281053.
    1. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Guideline: Integrated Addemdum to ICH E6(R1): Guideline for Good Clinical Practice (ICH-GCP). 2015. Available at: [Accessed July 9, 2021]
    1. Dwan K, Gamble C, Williamson PR, Altman DG. Reporting of clinical trials: a review of research funders’ guidelines. Trials. 2008;9(1):66. doi: 10.1186/1745-6215-9-66.
    1. Thomas L, Peterson ED. The value of statistical analysis plans in observational research: defining high-quality research from the start. JAMA. 2012;308(8):773–774. doi: 10.1001/jama.2012.9502.
    1. Gabriel SE. Getting the methods right--the foundation of patient-centered outcomes research. New Engl J Med. 2012;367(9):787–790. doi: 10.1056/NEJMp1207437.
    1. Zanarini MC. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Personal Dis. 2003;17(3):233–242. doi: 10.1521/pedi.17.3.233.22147.
    1. Juul S, Gluud C, Simonsen S, Frandsen FW, Kirsch I, Jakobsen JC. Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports. BMJ Evid Based Med. 2021;26(3):109. doi: 10.1136/bmjebm-2020-111407.
    1. Karterud S, Bateman A. Manual for mentalization based psychoeducational group therapy (MBT-I) Oslo: Gyldendal Akademisk; 2011.
    1. Pedersen G, Kvarstein EH, Wilberg T. The Work and Social Adjustment Scale: psychometric properties and validity among males and females, and outpatients with and without personality disorders. Personal Ment Health. 2017;11(4):215–228. doi: 10.1002/pmh.1382.
    1. Brazier JE, Harper R, Jones N, O’cathain A, Thomas K, Usherwood T, et al. Validating the SF-36 Health Survey Questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–164. doi: 10.1136/bmj.305.6846.160.
    1. Hall RC. Global assessment of functioning: a modified scale. Psychosom. 1995;36(3):267–275. doi: 10.1016/S0033-3182(95)71666-8.
    1. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale–preliminary report. Psychopharmacol Bull. 1973;9(1):13–28.
    1. Jakobsen JC, Ovesen C, Winkel P, Hilden J, Gluud C, Wetterslev J. Power estimations for non-primary outcomes in randomised clinical trials. BMJ Open. 2019;9(6):e027092. doi: 10.1136/bmjopen-2018-027092.
    1. Gratz K, Tull M, Levy R. Randomized controlled trial and uncontrolled 9-month follow-up of an adjunctive emotion regulation group therapy for deliberate self-harm among women with borderline personality disorder. Psychol Med. 2014;44(10):2099–2112. doi: 10.1017/S0033291713002134.
    1. Priebe S, Bhatti N, Barnicot K, Bremner S, Gaglia A, Katsakou C, Molosankwe I, McCrone P, Zinkler M. Effectiveness and cost-effectiveness of dialectical behaviour therapy for self-harming patients with personality disorder: a pragmatic randomised controlled trial. Psychother Psychosom. 2012;81(6):356–365. doi: 10.1159/000338897.
    1. Phillips R, Schneider J, Molosankwe I, Leese M, Foroushani PS, Grime P, McCrone P, Morriss R, Thornicroft G. Randomized controlled trial of computerized cognitive behavioural therapy for depressive symptoms: effectiveness and costs of a workplace intervention. Psychol Med. 2014;44(4):741–752. doi: 10.1017/S0033291713001323.
    1. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA. 2009;302(19):2095–103.
    1. Jørgensen CR, Freund C, Boye R, Jordet H, Andersen D, Kjolbye M. Outcome of mentalization-based and supportive psychotherapy in patients with borderline personality disorder: a randomized trial. Acta Psychiatr Scand. 2013;127(4):305–317. doi: 10.1111/j.1600-0447.2012.01923.x.
    1. Simonsen S, Heinskou T, Sørensen P, Folke S, Lau M. Personality disorders: patient characteristics and level of outpatient treatment service. Nordic J Psychiatry. 2017;71(5):325–31.
    1. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1355–1364. doi: 10.1176/appi.ajp.2009.09040539.
    1. StataCorp . Stata Statistical Software: release 16. College Station, TX: StataCorp LLC; 2019.
    1. Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med. 2011;31:328–340. doi: 10.1002/sim.4431.
    1. Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. BMJ. 2012;345(sep14 1):e5840. doi: 10.1136/bmj.e5840.
    1. Montgomery AA, Peters TJ, Little P. Design, analysis and presentation of factorial randomised controlled trials. BMC Med Res Methodol. 2003;3(1):26. doi: 10.1186/1471-2288-3-26.
    1. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18. doi: 10.1186/1741-7015-8-18.
    1. Jakobsen JC, Gluud C, Winkel P, Lange T, Wetterslev J. The thresholds for statistical and clinical significance - a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol. 2014;14(34):120-133.
    1. Zhang J, Quan H, Ng J, Stepanavage ME. Some statistical methods for multiple endpoints in clinical trials. Control Clin Trials. 1997;18(3):204–221. doi: 10.1016/S0197-2456(96)00129-8.
    1. Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567(7748):305–307. doi: 10.1038/d41586-019-00857-9.
    1. Goodman SN. Introduction to Bayesian methods I: measuring the strength of evidence. Clin Trials J Soc Clin Trials. 2005;2(4):282–290. doi: 10.1191/1740774505cn098oa.
    1. Demets DL, Lan KG. Interim analysis: the alpha spending function approach. Stat Med. 1994;13(13-14):1341–1352. doi: 10.1002/sim.4780131308.
    1. Guyatt GH, Briel M, Glasziou P, Bassler D, Montori VM. Problems of stopping trials early. BMJ. 2012;344(jun15 1):e3863. doi: 10.1136/bmj.e3863.
    1. Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials–a practical guide with flowcharts. BMC Med Res Methodol. 2017;17(1):162. doi: 10.1186/s12874-017-0442-1.
    1. Nielsen EE, Norskov AK, Lange T, Thabane L, Wetterslev J, Beyersmann J, et al. Assessing assumptions for statistical analyses in randomised clinical trials. BMJ Evid Based Med. 2019;24:185-9.
    1. Nørskov AK, Lange T, Nielsen EE, Gluud C, Winkel P, Beyersmann J, et al. Assessment of assumptions of statistical analysis methods in randomised clinical trials: the what and how. BMJ Evid Based Med. 2020;26(3):121–6.
    1. Frydenberg SJM. An introduction to Stata for health researchers, Fourth Edition. Stata Press; 2014.
    1. Oliveira AG. Biostatistics decoded. Wiley; 2013.
    1. Juul S, Poulsen S, Lunn S, Sørensen P, Jakobsen JC, Simonsen S. Short-term versus long-term psychotherapy for adult psychiatric disorders: a protocol for a systematic review with meta-analysis and trial sequential analysis. Sys Rev. 2019;8(1):169. doi: 10.1186/s13643-019-1099-0.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever